Home › Funds › CM Management, LLC › AVIR

CM Management, LLC position in AVIR

ATEA PHARMACEUTICALS INC · Health Care

CM Management, LLC reported holding 450,000 shares of AVIR (ATEA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.3M, representing 1.57% of its reported portfolio and ranking #25 among its reported holdings. CM Management, LLC has disclosed AVIR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)450.00K sh
Reported value held$2.34M
Portfolio Weight1.57%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CM Management, LLC's AVIR position evolved

CM Management, LLC first disclosed a stake in AVIR in Q3 2023 at 275,000 shares (US$825K). The position peaked in Q3 2026 at 450,000 shares, worth US$2.3M. Across 13 filings, CM Management, LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 450,000 shares valued at US$2.3M — an increase of 95,000 shares quarter over quarter.. Notable position changes include a 67% increase in Q1 2025 (shares rose 20% over the following quarter), a 29% trim in Q4 2025 (shares rose 51% over the following quarter), a 27% increase in Q3 2026 (shares fell 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 275.00K $825.00K New
Q4 2023 270.00K $823.50K Reduce
Q1 2024 270.00K $1.09M Hold
Q2 2024 270.00K $893.70K Hold
Q3 2024 270.00K $904.50K Hold
Q4 2024 300.00K $1.00M Add
Q1 2025 500.00K $1.50M Add
Q2 2025 500.00K $1.80M Hold
Q3 2025 500.00K $1.45M Hold
Q4 2025 355.00K $1.27M Reduce
Q1 2026 355.00K $1.91M Hold
Q2 2026 355.00K $1.65M Hold
Q3 2026 450.00K $2.34M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVIR and 13F data

AVIR (ATEA PHARMACEUTICALS INC) is a Health Care company. 29 other funds we track also report a position in AVIR — the largest reported positions include BML Capital Management, LLC (US$35.2M), TANG CAPITAL MANAGEMENT LLC (US$22.4M), Bain Capital Life Sciences Investors, LLC (US$9.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVIR

All AVIR fund holders →

FAQ

How long has CM Management, LLC held AVIR?

CM Management, LLC has disclosed AVIR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CM Management, LLC's current position in AVIR?

As of Q3 2026, CM Management, LLC holds 450.00K shares of AVIR (ATEA PHARMACEUTICALS INC), valued at $2.34M, representing 1.57% of its reported portfolio and ranking #25.

Has CM Management, LLC been buying or selling AVIR?

In the latest 13F filing (Q3 2026), CM Management, LLC increased its position in AVIR. The position peaked in Q3 2026 at 450.00K shares.

Which other funds hold AVIR?

Other major institutional holders of AVIR include BML Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Bain Capital Life Sciences Investors, LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.